Drug Trial Radar · NCT06579287
A Study of SHJ002 Sterile Ophthalmic Solution for Myopia Control
Last checked: Nov 19, 2026Latest source record: Jan 23, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
140
Actual
Start
Jan 22, 2025
Primary completion
Dec 2026
Study completion Dec 2026
Sponsor
- Lead sponsor
- Sunhawk Vision Biotech, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 30, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of this study is to explore the safety and efficacy of SHJ002 Sterile Ophthalmic Solution relative to atropine in myopia control SHJ002 is an antisense oligonucleotide to neutralize a specific microRNA.
Conditions
- Myopia, Progressive
Interventions
SHJ002Drug
Topical ophthalmic
AtropineDrug
Topical ophthalmic
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change of the cycloplegic spherical equivalent (SE)Time frame: from baseline visit to the final visit, up to 52 weeks
Locations
9 sites in 2 countries. Site status is shown where the registry gives one.
Pacific Center for Advanced Vision Care Tanasbourne Vision Center
Hillsboro, Ohio
Changhua Christian Hospital
Chang-hua, Taiwan
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
Chang Cung Memorial Hospital-Tucheng
New Taipei City, Taiwan
MacKay Memorial Hospital-Tamsui
New Taipei City, Taiwan
Chung Shan Medical University Hospital
Taichung, Taiwan
Cathay General Hospital
Taipei, Taiwan
Taipei Veterans General Hospital
Taipei, Taiwan
Tri-Service General Hospital
Taipei, Taiwan
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.